Centre Georges Francois Leclerc
Clinical trials sponsored by Centre Georges Francois Leclerc, explained in plain language.
-
New hope for Tough-to-Treat lung cancer: trial tests Triple-Threat therapy
Disease control Recruiting nowThis study is testing a new combination of drugs for people with a specific type of advanced lung cancer that has spread. The goal is to see if adding a short course of a drug called mirdametinib to standard chemotherapy and immunotherapy is safe and more effective at controlling…
Phase: PHASE1, PHASE2 • Sponsor: Centre Georges Francois Leclerc • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Cancer gene study tests if more data means better treatment choices
Knowledge-focused Recruiting nowThis study aims to determine whether a more detailed genetic analysis of tumors provides better treatment guidance than a standard analysis. Researchers will compare two approaches in nearly 8,000 adults with advanced cancer to see if the more complex analysis leads to different …
Phase: PHASE2 • Sponsor: Centre Georges Francois Leclerc • Aim: Knowledge-focused
Last updated Apr 01, 2026 21:56 UTC